Clinical Trial

The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)

Study acronym: ID-HFpEF
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Observational cohort randomized controlled study to study the influence of correction of ID by intravenous injection of ferric carboxymaltose (Ferinject®) on quality of life indicators, functional status in a cohort of patients with HFpEF.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-03-30; most recent amendment 2026-06-23.
Status change: Not Yet Recruiting → Recruiting 2023-04-28
Trial Details
NCT Number NCT05793996
Lead Sponsor Tomsk National Research Medical Center of the Russian Academy of Sciences
Conditions Chronic Heart Failure, Iron Deficiency, Latent
Enrollment 100 participants
Start Date 2023-04-28
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-24